The fifth epidermal growth factor like region of thrombomodulin alleviates LPS-induced sepsis through interacting with GPR15

Thrombosis and Haemostasis
Bin PanT Ikezoe

Abstract

Thrombomodulin (TM) exerts cytoprotection via the fifth region of epidermal growth factor (EGF)-like domain of TM (TME5) by interacting with G-protein coupled receptor 15 (GPR15) expressed on cell surface of vascular endothelial cells. TM is also implied to mediate anti-inflammatory functions by unknown mechanism. By applying a lipopolysaccharide (LPS)-induced murine sepsis model, we assessed the role of TME5 in septic inflammation and coagulation. We found that TME5 treatment protected mice in association with ameliorating inflammation and coagulopathy in LPS-induced sepsis. Further study confirmed that TME5 bound GPR15 in vitro. Knock out of GPR15 abolished protective role of TME5 in sepsis model. GPR15 mediated anti-inflammatory function of TME5 through suppression of phosphorylation of IκBα, nuclear translocation of NF-κB and release of pro-inflammatory cytokines in macrophages (Macs). Knock out of GPR15 resulted in dysregulated immune response of Macs, characterised by excessive expression of pro-inflammatory genes and failing to limit immune response. This study indicates that TME5 exerts anti-inflammatory function through inhibition of NF-κB in a GPR15-dependent manner. The use of TME5 may be a potential therapeutic opti...Continue Reading

References

Jul 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C T Esmon
Jul 1, 1996·Stem Cells·F Hirayama, M Ogawa
Jan 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thomas Vorup-JensenTimothy A Springer
Feb 7, 2003·Current Pharmaceutical Design·Daniel G Remick
May 22, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Bita ShakooryGuha Krishnaswamy
Feb 16, 2005·Thrombosis and Haemostasis·Andrew D BlannFrançoise Dignat-George
May 19, 2006·Journal of Thrombosis and Haemostasis : JTH·N MaugeriC Cerletti
Oct 10, 2007·Molecular and Cellular Biology·Sergio RuizXosé R Bustelo
Sep 20, 2008·Nature Reviews. Immunology·Daniel RittirschPeter A Ward
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Apr 28, 2009·The Lancet Infectious Diseases·Emma Lappin, Andrew J Ferguson
May 26, 2009·Immunity·Liang ZhouDan R Littman
May 12, 2010·The Journal of Clinical Investigation·Chunzhang CaoLi Zhang
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·T Ito, I Maruyama
Mar 2, 2012·The Journal of Clinical Investigation·Antonio Sica, Alberto Mantovani
Nov 16, 2013·Nature Reviews. Immunology·Richard S HotchkissDidier Payen
Dec 18, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Bin PanKailin Xu
Apr 15, 2014·Cytokine·Alison CartwrightJim Middleton
May 20, 2014·European Journal of Immunology·Katharina LahlEugene Butcher
Aug 5, 2014·International Immunology·Osamu Yoshie, Kouji Matsushima
Oct 2, 2014·The Journal of Clinical Investigation·Agnieszka DejdaPrzemyslaw Sapieha
Nov 25, 2014·Journal of Internal Medicine·S M Opal, T van der Poll
Dec 21, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alejandro V VillarinoJohn J O'Shea
Dec 23, 2014·Nature Immunology·Linh P NguyenAida Habtezion
Jan 27, 2015·Annual Review of Immunology·Qian YinHao Wu
Mar 20, 2015·Nature Immunology·Akiko Iwasaki, Ruslan Medzhitov
Aug 1, 2015·Genes and Immunity·N Packiriswamy, N Parameswaran
Nov 13, 2015·Expert Opinion on Therapeutic Targets·Takashi ItoIkuro Maruyama

❮ Previous
Next ❯

Citations

Jun 16, 2017·Molecular Biology of the Cell·Yukari Okamoto, Sojin Shikano
Sep 14, 2017·Science Signaling·Thomas SuplyFrédéric Bassilana
Jan 23, 2019·Journal of Experimental & Clinical Cancer Research : CR·Ying ZhangYongping Wu
Apr 29, 2021·Trends in Immunology·Daolin TangRui Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.